Healthcare & Life Sciences
Velicept
United Kingdomwww.velicept.com
Velicept is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series B, 1 tracked investor.
Defunctseries-b
series-b
Stage
1
Investors
About Velicept
Velicept is a company headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Velicept developed solabegron, a selective beta-3 adrenergic receptor agonist aimed at treating overactive bladder (OAB) and irritable bowel syndrome (IBS). The company ceased operations in 2020.
Explore Velicept's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.